Overall Assessment: The stock has experienced significant volatility over the past six months, with a sharp decline from October 2025 into November, followed by a strong rally peaking in late January 2026, and a subsequent correction. The 6-month price change is -2.30%, indicating a slight net decline over the period, but the stock has significantly outperformed the S&P 500 by 0.52% over the same timeframe.

Short-term Performance: The stock has declined 13.44% over the past month, underperforming the S&P 500's -5.25% return. However, it has gained 1.40% over the past three months, outperforming the S&P 500's -4.63% return. The most recent trading day saw a 7.58% increase from $60.06 to $64.61.

Current Position: The current price of $64.61 is approximately 22.5% below its 52-week high of $83.35 and 89.3% above its 52-week low of $34.13, positioning it in the upper-mid range of its yearly band. The stock's beta of 1.45 indicates higher volatility than the broader market.

Revenue & Profitability: Revenue for the latest quarter (Q3 2026) was $1.186 billion, representing a 15.6% year-over-year growth. However, profitability is inconsistent; the quarterly net income was $34.9 million (net margin of 2.9%), but the trailing twelve-month metrics show a near-zero net margin (-0.01%) and negative EPS. The gross margin of 59.6% in the latest quarter is healthy, but the operating margin of 12.8% is pressured.

Financial Health: The company maintains a strong current ratio of 2.59, indicating good short-term liquidity. The debt-to-equity ratio is 0.80, suggesting a moderate level of leverage. Free cash flow over the TTM is a solid $819.9 million, providing financial flexibility.

Operational Efficiency: Return metrics are currently weak, with a Return on Assets (ROA) of 1.16% and a Return on Equity (ROE) of -0.007%. This reflects the recent period of low or negative profitability. The quarterly asset turnover of 0.083 suggests room for improved efficiency in generating sales from its asset base.